Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent
Mohd Zobir Hussein1,2, Samer Hasan Al Ali2, Zulkarnain Zainal2, Muhammad Nazrul Hakim31Advanced Materials and Nanotechnology Laboratory, Institute of Advanced Technology (ITMA), 2Department of Chemistry, Faculty of Science, 3Department of Biomedical Science, Faculty of Medicine and Health Science, U...
Enregistré dans:
Auteurs principaux: | Hussein MZ, Al Ali SH, Zainal Z, Hakim MN |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/58f6b7ae817a46a5a8f747875d10d0e7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines
par: Hussein Al Ali SH, et autres
Publié: (2011) -
Anticancer nanodelivery system with controlled release property based on protocatechuate–zinc layered hydroxide nanohybrid
par: Barahuie F, et autres
Publié: (2014) -
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite
par: Hussein Al Ali SH, et autres
Publié: (2012) -
Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
par: Hussein Al Ali SH, et autres
Publié: (2012) -
Presynaptic Release-Regulating Alpha2 Autoreceptors: Potential Molecular Target for Ellagic Acid Nutraceutical Properties
par: Isabella Romeo, et autres
Publié: (2021)